$LAB Income Statement | Understand Stock

$LAB

$0.62 +$0.02 (2.68%) Close

$LAB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Product revenue
Service and other revenue
Other revenue
Service revenue
Development revenue
Collaboration and other revenue
Services and other revenue
Total revenue

Cost of revenue:
Product revenue
Service and other revenue
Service revenue
Collaboration and other revenue
Services and other revenue
Total cost of revenue
Gross profit
Operating expenses:
Research and development
Selling, general and administrative
Restructuring and related charges
Transaction and integration expenses
Total operating expenses
Loss from continuing operations
Bargain purchase gain
Loss on forward sale of Series B Preferred Stock
Loss on Bridge Loans
Surplus funding from NIH Contract
Loss from extinguishment of debt
Interest income
Interest expense
Other income (expense), net
Loss before income taxes
Income tax benefit (expense)
Net loss from continuing operations
Discontinued operations:
Loss from discontinued operations, net of tax
Net loss
Less: Induced conversion of redeemable preferred stock
Net loss attributable to common stockholders
Net loss per share from continuing operations, basic (in dollars per share)
Net loss per share from continuing operations, diluted (in dollars per share)
Net loss per share from discontinued operations, basic (in dollars per share)
Net loss per share from discontinued operations, diluted (in dollars per share)
Net loss per share attributable to common stockholders, basic (in dollars per share)
Net loss per share attributable to common stockholders, diluted (in dollars per share)
Shares used in computing net loss per share attributable to common stockholders, basic (in shares)
Shares used in computing net loss per share attributable to common stockholders, diluted (in shares)

Comments